✦ LIBER ✦

Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors

✍ Scribed by Andreas Kaubisch; Ron Kaleya; Hilda Haynes; Alla Rozenblit; Scott Wadler

Publisher: Springer
Year: 2004
Tongue: English
Weight: 178 KB
Volume: 53
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0727-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of PALA and 6-methylmerca

Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer

✍ Istvan Redei; Fran Green; John P. Hoffman; Louis M. Weiner; Richard Scher; Peter 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 254 KB

A phase II trial of alpha-interferon and

A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors

✍ Leonard Saltz; Nancy Kemeny; Gary Schwartz; David Kelsen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB 👁 2 views

Phase II trial of streptozotocin, mitomy

Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer

✍ R. Glen Wiggans; Paul V. Woolley III; John S. Macdonald; Tarilyn Smythe; Winston 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Two randomised phase II trials of interm

Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer

✍ P. I. Clark; M. L. Slevin; R. H. Reznek; N. Niederle; E. Kurschel; G. Lundell; B 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 380 KB

Phase II clinical trial of SKI-2053R, a

Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

✍ Noe K. Kim; Seock-Ah Im; Dong-Wan Kim; Moon H. Lee; Chul W. Jung; Eun K. Cho; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

BACKGROUND. SKI-2053R (SK Chemicals, Kyungki-Do, South Korea) is a new platinum derivative with antitumor activity against various cell lines, including cisplatin-resistant tumor cell lines. Preclinical studies have suggested that it is less nephrotoxic than cisplatin. This study evaluated the effic

Phase II multicenter trial of docetaxel,

Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen

✍ André M. Murad; Nils G. Skare; Jéferson Vinholes; Sérgio Lago; Ricardo Pecego; B 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 362 KB